Non-coding RNA Related to Cancer Therapy
Resistance and Cancer Recurrence


What can CTRR-ncRNA provide?

1. An atlas of non-coding RNAs related to cancer resistance and cancer recurrence.
2. A collection of biomarkers for cancer resistance and cancer recurrence in different cancers.
3. Clinical information of patients with cancer resistance and recurrence

News

April, 2022
1.Non-coding RNAs Related to Cancer Therapy Resistance records: 708
2.Non-coding RNAs Related to Cancer Recurrence records: 67
3.Universal Non-coding RNAs records: 200

What is CTRR-ncRNA?

Conventional treatment methods might fail to eliminate cancer cells in the body and it may even lead to treatment resistance. Increasing evidence shows that non-coding RNAs play critical roles in cancer resistance and cancer recurrence. CTRR-ncRNA is the first public database that curates experimentally supported data related to non-coding RNAs related to cancer resistance and cancer recurrence from published literature, aiming to provide a comprehensive and precise resource for research on treatment resistance and recurrence prevention. Currently, CTRR-ncRNA contains detailed information consisting of 2800 records , including the type of cancer, the expression of ncRNA in cancer tissues or cells, and the effect of ncRNA on the drug resistance of cancer tissues or cell lines, non-coding RNA- expression difference between relapsed and non-relapsed patients, patients' clinical information and participating countries, etc.